A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
BackgroundRosacea, a chronic inflammatory skin disorder etiologically associated with immune cells and the antibacterial peptide cathelicidin LL-37, can be effectively treated by oral carvedilol administration.ObjectiveTo investigate the molecular mechanisms underlying carvedilol efficacy in rosacea...
Main Authors: | Jiawen Zhang, Peiyu Jiang, Lei Sheng, Yunyi Liu, Yixuan Liu, Min Li, Meng Tao, Liang Hu, Xiaoyan Wang, Yanjing Yang, Yang Xu, Wentao Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.609615/full |
Similar Items
-
Corrigendum: A Novel Mechanism of Carvedilol Efficacy for Rosacea Treatment: Toll-Like Receptor 2 Inhibition in Macrophages
by: Jiawen Zhang, et al.
Published: (2022-03-01) -
Long-term management of distinct facial flushing and persistent erythema of rosacea by treatment with carvedilol
by: Katharina Pietschke, et al.
Published: (2018-04-01) -
Skin barrier in rosacea
by: Flavia Alvim Sant'Anna Addor
Published: (2016-02-01) -
Rosacea pathogenesis and therapeutics: current treatments and a look at future targets
by: Garrett W. Fisher, et al.
Published: (2023-12-01) -
The role of macrophages in rosacea: implications for targeted therapies
by: Yi Liu, et al.
Published: (2023-08-01)